Associations of HLA class I alleles in Japanese patients with Crohn's disease

D Oryoji1, T Hisamatsu2, K Tsuchiya3

  • 1Institute for Advanced Study, Kyushu University, Fukuoka, Japan.

Genes and Immunity
|November 7, 2014
PubMed

Insights

Human leukocyte antigen (HLA) class I genes influence Crohn's disease (CD) development in Japan. This study found specific HLA alleles associated with both increased susceptibility and resistance to CD.

Area of Science:

  • Immunogenetics
  • Gastroenterology
  • Human Molecular Genetics

Background:

  • The human leukocyte antigen (HLA) system plays a crucial role in immune responses.
  • Previous research suggests HLA involvement in Crohn's disease (CD) etiology.
  • Limited data exists on HLA class I antigen associations with CD in the Japanese population.

Purpose of the Study:

  • To investigate the association between HLA class I antigens and Crohn's disease in a Japanese cohort.
  • To identify specific HLA alleles that confer susceptibility or resistance to CD.

Main Methods:

  • Case-control association analysis.
  • Utilized 208 Japanese patients with Crohn's disease and 384 healthy controls.
  • Examined HLA class I antigen frequencies.

Main Results:

  • Identified novel positive associations between CD and HLA-A*02:01 and HLA-A*02:07.
  • Confirmed associations for HLA-Cw*14:02 and HLA-B*51:01.
  • Discovered novel negative associations with HLA-A*24:02 and HLA-B*07:02, suggesting protective roles.

Conclusions:

  • HLA class I genes exhibit dual roles in Crohn's disease, influencing both susceptibility and resistance.
  • These findings contribute to understanding the genetic basis of CD in Japan.
  • Further research is warranted to elucidate the mechanisms underlying these associations.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
19
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
734
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.1K
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
17
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
22